Viatris Stock: A Global Pharmaceutical Leader with a Diversified Portfolio and Cost-Efficient Manufacturing Model.

Viatris Inc. (VTRS) is a global pharmaceutical and healthcare company with a market cap of $15.2 billion. Its shares have soared 39.8% over the past 52 weeks, outperforming the State Street Health Care Select Sector SPDR Fund (XLV) by 38.7%. VTRS has been trading above its 200-day moving average since late September and has slipped under its 50-day moving average recently. However, the company faces ongoing internal transition challenges, including restructuring charges, remediation costs, and manufacturing-related disruptions.